Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
Year: 1997
Type: article
Abstract: Vessel wall subendothelial extracellular matrix, a dense mesh formed of collagens, fibronectin, laminin, and proteoglycans, has important roles in lipid and lipoprotein retention and cell adhesion.In atherosclerosis, vessel wall heparan sulfate proteoglycans (HSPG) are decreased and we therefore tested whether selective loss of HSPG affects lipoprotein retention.A matrix synthesized by aortic endothelial cells and a commercially available matrix (Matrigel; Becton Dickinson Inc., Rutherford, NJ) were used.Treatment of matrix with heparinase/heparitinase (1 U/ml each) increased LDL binding by ف 1.5-fold.Binding of lipoprotein (a) [Lp(a)] to both subendothelial matrix and Matrigel ® increased 2-10-fold when the HSPG were removed by heparinase treatment.Incubation of endothelial cells with oxidized LDL (OxLDL) or lysolecithin resulted in decreased matrix proteoglycans and increased Lp(a) retention by matrix.The effect of OxLDL or lysolecithin on endothelial PG was abolished in the presence of HDL.The decrease in matrix HSPG was associated with production of a heparanase-like activity by OxLDL-stimulated endothelial cells.To test whether removal of HSPG exposes fibronectin, a candidate Lp(a) binding protein in the matrix, antifibronectin antibodies were used.The increased Lp(a) binding after HSPG removal was inhibited 60% by antifibronectin antibodies.Similarly, the increased Lp(a) binding to matrix from OxLDLtreated endothelial cells was inhibited by antifibronectin antibodies.We hypothesize that atherogenic lipoproteins stimulate endothelial cell production of heparanase.This enzyme reduces HSPG which in turn promotes Lp(a) retention.( J. Clin.Invest.1997.100:867-874.)Key words: pro- teoglycans • arteriosclerosis • heparin • endothelial cells • oxidized LDL MethodsMaterials.L -lysophosphatidylcholine (lysolecithin) from bovine brain was from Sigma Chemical Co.(St.Louis, MO).L -[4,5-3 H]leucine (147 Ci/mmol) and [ 35 S]sulfate aqueous solutions were from Amersham Corp. (Arlington Heights, IL).Heparinase and heparitinase were purchased from either Sigma Chemical Co. or Seikagaku America Inc. (Bethesda, MD).Chondroitin ABC lyase was from Seikagaku America Inc. 1 U will form 0.1 mol of unsaturated uronic acid/h.
DOI: 10.1172/jci119602
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2050385895
